APOLLOHOSPNSEApollo Hospitals Enterprise Limited· Healthcare ServicesHighPositive
Announced Tue, 27 Jan, 2026 · 18:18 IST

Apollo Hospitals outlook revised to Positive by CRISIL, ratings reaffirmed at AA+

APOLLOHOSP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.8%Reaction day
₹6820.00
prior close
₹6798.50
announcement price
After-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.9%-0.2% vs market
Hospital peers, median of 23sector+0.1%+0.6% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty 100 and 0.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.0
10m
+0.5
15m
+0.8
30m
+0.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.8+0.9-0.2+0.1+0.6
Next day
-0.1+1.2-1.4-0.6+0.5
2d
+1.9+0.8+1.1+1.9+0.0
3d
+1.5-0.2+1.7+0.2+1.3
4d
+3.6+2.4+1.2+1.4+2.2
5d
+4.1+2.6+1.5+1.5+2.6
1w
+4.5+2.3+2.2+1.4+3.1
15d
+12.1+3.0+9.1+2.0+10.1
1m
+14.1-0.6+14.6+1.3+12.8
2m
+10.0-11.0+21.0-7.4+17.4
3m
+13.5-2.9+16.4+6.5+7.0
UpDownMarket · Nifty 100Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CRISIL revised the outlook on Apollo Hospitals' long-term ratings to Positive from Stable, while reaffirming ratings at CRISIL AA+ on Rs. 2,800 crore bank facilities and NCDs. Short-term rating reaffirmed at CRISIL A1+. Backed by Rs 3,222 crore cash surplus, 51 hospitals with 9,500 plus beds, 13.9 percent operating margin in FY25, and strong cash accruals of over Rs 2,000 crore. Capex plan of Rs 6,000 crore planned over 3-5 years.

Likely market impact

Positive outlook reflects CRISIL's confidence in strong financials, dominant market position, and healthy cash generation, a favourable credit signal for shareholders.